Hinten F, van den Einden L C G, Cissen M, IntHout J, Massuger L F A G, de Hullu J A
Radboud University Medical Centre, Department of Obstetrics and Gynaecology, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Radboud University Medical Centre, Department of Obstetrics and Gynaecology, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
Eur J Surg Oncol. 2015 Apr;41(4):592-8. doi: 10.1016/j.ejso.2015.01.002. Epub 2015 Jan 14.
The overall 5-year survival of patients with vulvar squamous cell carcinoma (SCC) is 70%. The clinical impression is that localization of SCC on the clitoris may lead to worse prognosis. The aim of this study is to assess the disease specific survival (DSS) in patients with clitoral SCC compared to patients with SCC without clitoral involvement.
All consecutive patients with primary vulvar SCC treated with surgery at the Department of Gynaecologic Oncology at the Radboud university medical centre (Radboudumc) between March 1988 and January 2012, were analysed. The clinical and histopathological characteristics and DSS rates of patients with (N = 72) and without clitoral SCC (N = 275) were compared. Furthermore, patients with clitoral involvement were compared to patients with perineal SCCs (N = 52) and other central SCCs without clitoral and/or perineal involvement (N = 117).
Patients with clitoral SCC more often had larger and deeper invaded tumours, lymphovascular space involvement (LVSI), positive surgical margins and a higher percentage of positive lymph nodes. Kaplan-Meier survival analyses showed worse DSS in patients with a clitoral SCC compared to patients without clitoral involvement. Multivariable analysis showed that not clitoral involvement, but invasion depth, differentiation grade and lymph node status are independent prognostic factors.
Patients with clitoral SCC have worse survival compared to patients without clitoral involvement. This is probably caused by unfavourable histopathological characteristics of the tumour rather than the localization itself. Prospective studies are needed to further assess the influence of localization of the vulvar SCC on prognosis.
外阴鳞状细胞癌(SCC)患者的总体5年生存率为70%。临床印象是,SCC发生于阴蒂可能导致更差的预后。本研究的目的是评估阴蒂SCC患者与未累及阴蒂的SCC患者的疾病特异性生存率(DSS)。
对1988年3月至2012年1月期间在拉德堡德大学医学中心(Radboudumc)妇科肿瘤学系接受手术治疗的所有连续性原发性外阴SCC患者进行分析。比较了有(N = 72)和无阴蒂SCC(N = 275)患者的临床和组织病理学特征及DSS率。此外,将累及阴蒂的患者与会阴SCC患者(N = 52)以及其他未累及阴蒂和/或会阴的中央SCC患者(N = 117)进行了比较。
阴蒂SCC患者的肿瘤通常更大、浸润更深,存在淋巴管间隙浸润(LVSI)、手术切缘阳性以及阳性淋巴结百分比更高。Kaplan-Meier生存分析显示,与未累及阴蒂的患者相比,阴蒂SCC患者的DSS更差。多变量分析表明,不是阴蒂受累,而是浸润深度、分化程度和淋巴结状态是独立的预后因素。
与未累及阴蒂的患者相比,阴蒂SCC患者的生存率更差。这可能是由肿瘤不利的组织病理学特征而非其部位本身所致。需要进行前瞻性研究以进一步评估外阴SCC部位对预后的影响。